Cancer Medical Cannabis Studies

• View All (505)

Targeting CB2-GPR55 Receptor Heteromers Modulates Cancer Cell Signaling (2014)

The G protein-coupled receptors CB2 (CB2R) and GPR55 are overexpressed in cancer cells and human tumors. Because a modulation of GPR55 activity by cannabinoids has been suggested, in this investigation an analysis was made on whether this receptor participates in the effects of cannabinoids on cancer cells. View study
The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids (2015)

This research will aim to study the mechanisms by which non-psychoactive cannabidiol (CBD) and other cannabinoids derived from plants are inefficient to activate cannabinoid receptors, inhibit the viability of tumor cells, invasion, metastasis, angiogenesis and the stem-like potential of cancer cells. View study
The effects of cannabidiol and its synergism with bortezomib in multiple myeloma cell lines. A role for transient receptor potential vanilloid type-2 (2014)

Multiple myeloma (MM) is a plasma cell (PC) malignancy characterized by the accumulation of a monoclonal PC population in the bone marrow (BM). This research was based on the study of the effects of cannabidiol and its synergism with bortezomib in multiple myeloma cell lines. View study
The effects of Positive Youth Development interventions on substance use, violence and inequalities: systematic review of theories of change, processes and outcomes (2016)

The positive development of youth that takes place outside of school aims to enable young people to develop positive assets, such as relationships and trust, instead of just addressing risk, violence, alcohol and illicit drugs. View study
The endocannabinoid system and cancer: therapeutic implication (2011)

The endocannabinoid system is implicated in a variety of physiological and pathological conditions. This research focused on the study of how endocannabinoid activation affects breast, prostate and bone cancers in the in vitro and in vivo systems. View study
The endocannabinoid system in cancer- Potential therapeutic target? (2008)

The present study has as objective the revision of several means by which the endocannabinoid system can be attacked in cancer and the current knowledge considering the regulation of the endocannabinoid system in the malignancy. View study
The Expression Level of CB1 and CB2 Receptors Determines Their Efficacy at Inducing Apoptosis in Astrocytomas (2010)

It is desired to analyze in this research whether the level of expression of CB1 and CB2 receptors determines its efficacy in the induction of apoptosis in astrocytomas View study
The intersection between cannabis and cancer in the United States (2012)

In the last 15 years, there has been a major change in the laws governing the medical use of cannabis in the United States. The present review focused on examining the current and potential roles of cannabis and cannabinoids in cancer care View study
The Use of Medical Marijuana in Cancer. (2016)

The use of medical marijuana in the treatment of cancer presents a dilemma for both patients and doctors. The purpose of this review was to address the current state of the research, including potential indications, risks and adverse effects, preliminary data on anticancer effects, as well as legal and quality issues. View study
Therapeutic use of Cannabis sativa on chemotherapy-induced nausea and vomiting among cancer patients: systematic review and meta-analysis (2008)

The present research focused on the use of cannabis as a therapeutic agent to treat nausea and vomiting induced by chemotherapy in cancer patients View study